Summary When human melanoma cells are injected into nude mice they usually give rise to tumours that grow progressively and do not elicit a prominent host response. We have recently developed a melanoma cell line, UCT-Mel 7, that did not show these characteristics.
Solid tumours growing in vivo comprise two distinct components. The first of these is made up of neoplastic cells while the second is the complex supporting stroma that consists of mesenchymal cells and the various macromolecular structural elements that characterise connective tissues (Robbins et al., 1984) .
The amount of stroma varies from one tumour to another. In anaplastic carcinomas and sarcomas it is usually scanty and devoid of recognisable structure, whereas in most welldifferentiated malignant tumours and in benign tumours, the stroma is moderate and ordered. One also encounters a third category of neoplasms, such as the scirrhous carcinomas, where the stroma is so abundant and dense that it contributes substantially to the mass of the tumour (Willis, 1967) . The development of fibrous stromal tissue within and around a tumour is referred to as desmoplasia (Liotta, 1982; Robbins et al., 1984) and it is generally believed that the desmoplastic response reflects the host mesenchymal reaction to the presence of neoplastic cells.
Although desmoplastic tumours are commonly encountered clinically, the significance of the fibrous tissue response is uncertain. It (Azar et al., 1980) were reared from stocks generously provided by Dr B. Giovanella, Houston, Texas, and were maintained under sterile conditions. For the experiments we used 8-12-week-old progeny of nu/+ mothers and nu/nu fathers.
Inoculation into nude mice Melanoma cells were released from the culture vessels with 0.25% trypsin and 0.02% EDTA in Tris-buffered saline (0.14 M NaCl, 5 mm KCI, 0.7 mm Na phosphate, 25 mM Tris-HCI; pH 7.4) and immediately resuspended in RPMI-1640 containing 10% fetal calf serum. The cells were pelleted, resuspended in serum-free RPMI-1640 at a concentration such that the desired inoculum (usually 1 to 5 x 106 cells) was contained in 0.1 ml, and injected subcutaneously between the scapulas. Direct passage of tumours from one animal to another was accomplished by implanting small fragments of the tumour into the subcutaneous tissues. Mice were examined and their tumours were measured weekly. The technique used for transfer (i.e. as cells or as fragments) had no obvious effect upon in vivo growth kinetics of the tumours that subsequently developed. Tumour volumes were calculated as the products of three major diameters.
Examination of tumours
Tumours were removed and divided into representative portions for histology, passage in vivo or biochemical analysis.
Br. J. Cancer (1992), 65, 487-490 Formalin-fixed samples were embedded in paraffin, sectioned and stained according to standard histological techniques. Sections of the tumours were stained for reticulin according to the method of Gordon & Sweets (1936) .
The hydroxyproline content of the tumours was determined colorimetrically using the method of Hutterer & Singer (1960) in which tissues were hydrolysed in 6 N HCl, dried in vacuo and the residue dissolved in distilled water. The absorbance was read at 500 nm and 560 nm, after adding p-dimethylaminobenzaldehyde, and referred to a hydroxyproline standard curve.
Results
Growth characteristics of UCT-Mel 7-derived tumours It has been our consistent experience that inocula of malignant melanoma cells typically give rise to tumours that develop shortly after inoculation and that grow relentlessly and exponentially thereafter.
UCT-Mel 7 cells grew differently (Figure 1 ). In most cases five distinct sequential phases could be discerned:
1. a period of early latency followed by a short period of exponential growth that lasted approximately 10 days.
2. This was followed by a plateau phase during which the size of the tumour remained constant. This lasted for 70-100 days.
3. A phase of regression then ensued, during which time the tumour diminished in size, frequently becoming barely perceptible.
4. This was followed by a period of dormancy which was broken, by now 4-7 months after inoculation, by 5. a phase of aggressive, exponential growth. Not all tumours showed all five phases of growth. In some, rapid exponential growth (phase 5) followed a short period of regression without the quiescent phase 4 (Figure lb (Figure 2) . UCT-Mel 7 was, therefore, unique in inducing a desmoplastic response. Despite the intense fibrotic response within the tumour, the mass was readily separable from adjacent normal tissues that showed remarkably little mesenchymal reaction to the melanoma xenograft.
The collagen content of UCT-Mel 7 tumours varied with the phase of growth. As stated above, tumours removed during phase 2 had a hydroxyproline content of 67.6 ± 9.5 pg mg-' cellular protein, whereas the hydroxyproline content of phase 5 tumours and phase 5 tumours that had been passaged in vivo was negligible (1.1 ± 0.6 and 1.0 ± 0.4 jig mg-' cellular protein, respectively) and not significantly different from that of tumours derived from UCT-Mel 1-5 (Figure 2 ).
Histological appearances of UCT-Mel 7-derived tumours
The histological appearance of the UCT-Mel 7-derived tumours at different phases are shown in Figure 3 . Tumours removed during phase 2 were well differentiated tumours composed of spindle shaped melanoma cells embedded in a dense fibrous stroma. Silver staining revealed an abundant reticulin network that surrounded individual tumour cells. Tumours removed during phase 5, although less obviously differentiated, still retained their spindle shaped morphology. Collagen deposition and reticulin fibre formation were virtually absent.
Discussion
The tumours that developed when UCT-Mel 7 cells were inoculated into nude mice were consistently unusual in that they started as slowly growing or dormant tumours that elicited an intense fibrogenic response and subsequently progressed to become rapidly growing tumours that were not desmoplastic.
In a sense this corresponds with a teleological view of desmoplasia that sees the response as an attempt by the host to 'wall off' the tumour both physically and immunologically (Liotta, 1982) . But whether, as is implied by this view, the desmoplastic response is beneficial to the host is debatable. Desmoplasia has been variously associated with an adverse (Cantin et al., 1982; Halvorsen & Seim, 1989) or a favourable (Seemayer et al., 1980) prognosis for growth and spread of the tumour.
Our observations have shown that the apparent quiescence that was associated with desmoplasia was invariably terminated by an alteration in the innate characteristics of the restrained cells which progressed to develop into the rapidly growing tumours seen in phase 5. The new phenotype was stable since passage into fresh recipients gave rise to tumours with similar characteristics and with neither the dormant nor the desmoplastic features of the original xenografts. It is one of the characteristics of tumour progression that tumour cell populations increase their growth rate. This is not due to a shortening of the cell cycle time but rather to progressive mutations that lead to an increase in that popultion of cells within the tumour whose proliferation is no longer balanced by terminal differentiation or cell death (Nowell, 1986) . If one accepts this view our observations would suggest a complex interaction between host and tumour in which asymmetrical division (Burgess & Nicola, 1983 ) of a small number of stem cells in the original xeno- The intensity of the fibrosis raises two questions: the first relating to the nature of the fibrogenic signal and the second to the significance of the stromal response.
It is known that cytokines such as transforming growth factor beta (TGF-,B) are capable of inducing collagen synthesis (Ignotz et al., 1987; Raghow et al., 1987; Roberts et al., 1988) and basic fibroblast growth factor (bFGF) is known to be elaborated by melanoma cells (Halaban et al., 1988; Becker et al., 1989) and to stimulate fibroblast proliferation (Gospodarowicz, 1987) . Experiments to assess the role of these mediators in our system are currently in progress.
As far as the significance of the desmoplastic reaction is concerned a number of possibilities exist. The stroma, by mediating cellular interactions with growth factors (Vlodavsky et al., 1987; Roberts et al., 1988; Saksela et al., 1988) may have exerted indirect differentiation pressures upon the tumour cells to maintain asymmetric division; alternatively the fibrosis may have been an epi-phenomenon with no effect upon the phenotype. With this model, these possibilities are now testable.
There appears to be only one other animal model that might be used to address the important issues that concern desmoplasia. This was described by Barsky & Gopalakrishna (1987) who found that BL6 mouse melanoma cells inoculated into 18-month-old C57BL/6 mice elicited a desmoplastic response that could be inhibited by the administration of L-3,4-dehydroproline. In their model, the induction of desmoplasia was age-dependent since it was seen only in 18-month-old mice; tumours in 6-week-old-mice were not fibrotic. In our system the induction of a fibrous response was determined by the cell line used and should provide a useful means of defining host:tumour relationships that are independent of age and that have relevance to the human clinical situation.
In conclusion, we would stress that, by measuring collagen content of the tumours, we have examined only one component of the highly complex assembly of macromolecules that constitute the extracellular matrix (for review see LabatRobert et al., 1990) . We are currently applying our model to the study of elastin, proteoglycan and structural glycoprotein metabolism in desmoplasia.
